drugset
drugset / Trial / NCT01857609

Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin

NCT01857609 ↗

Phase 1 Completed 24 enrolled Seoul National University Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to investigate the effect of proton pump inhibitor on the pharmacokinetics and pharmacodynamics of metformin in healthy Korean men.

Timeline

Start
2012-08
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —
Subject Pantoprazole Other / unclassified 40 mg —
Subject Rabeprazole Small molecule 20 mg —

Indications

No indication recorded.